Clinical Trials Directory

Trials / Unknown

UnknownNCT02149563

Oxygen Therapy in Depression

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The major objective of the present study is to examine the influence of normobaric hyperoxia treatment on the symptoms of patients diagnosed with depression members of Clalit Health Services. The investigators hypothesize that normobaric hyperoxia treatment will improve the symptoms of patients with depression.

Conditions

Interventions

TypeNameDescription
DEVICEoxygen-enriched air -Normobaric hyperoxia treatment for depressionForty percent oxygen or regular air will be supplied from oxygen concentrators, through standard plastic nasal prongs, at a flow rate of 5 liters/minute, for 7 hours a day, throughout the night.

Timeline

Start date
2015-01-01
Primary completion
2016-04-01
Completion
2016-09-01
First posted
2014-05-29
Last updated
2015-03-17

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02149563. Inclusion in this directory is not an endorsement.